US Stocks
/
iBio, Inc. Share Price

iBio, Inc. Share Price

NASDAQ: IBIO | Micro Cap
$0.88
-$0.03 (-3.49%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

iBio, Inc. Stock Performance

Open
$0.93
Prev. Close
$0.91
Circuit Range
N/A
Day Range
$0.86 - $0.95
Year Range
$0.79 - $3.76
Volume
36,303
Average Traded
$0.88

iBio, Inc. Share Price Today

As of 10 October 2026, iBio, Inc.'s share price is $0.88. The stock opened at $0.93, compared to its previous close of $0.91. During today's trading session, iBio, Inc.'s share price traded between $0.86 and $0.95, with an average price of $0.90. Over the past 52 weeks, the stock has recorded a high of $3.76 and a low of $0.79. In terms of performance, iBio, Inc.'s share price has declined by 48.35% over the last six months and is down 44.95% on a year-on-year basis.

iBio, Inc. Share Price Chart

$0.86$0.95
L
Show Current Price
H

iBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.37
Revenue (TTM)
$100.00M
Return On Equity (TTM)
-28.07%
Profit Margin
-33040.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-84.97%

iBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.10$0.00$0.00$0.00
Net Profit-$5.72$0.00-$7.76-$10.58
Net Profit Margin-5720.00%N/AN/AN/A
Income ChangeN/A100.00%N/A-36.34%

iBio, Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.23$0.40$0.10
Net Profit-$65.01-$24.91-$18.38-$33.04
Net Profit MarginN/A-10830.43%-4595.00%-33040.00%
Income ChangeN/A61.68%26.21%-79.76%

About iBio, Inc.

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

iBio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.18
$0.88
-25.51%
Sep 2026
$1.26
$1.18
-16.01%
Aug 2026
$1.42
$1.41
-0.35%
Jul 2026
$1.77
$1.41
-19.20%
Jun 2026
$1.91
$1.75
-8.40%
May 2026
$1.62
$1.91
+12.06%
Apr 2026
$1.96
$1.70
-10.99%
Mar 2026
$2.56
$1.91
-32.63%
Feb 2026
$2.06
$2.83
+34.04%
Jan 2026
$1.93
$2.12
+8.46%
Dec 2025
$1.19
$1.95
+59.18%
Nov 2025
$1.65
$1.23
-23.20%

IBIO Share Price FAQs

What is iBio, Inc. share price today?

chevron-up
iBio, Inc. share price today is $0.88 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of iBio, Inc. stock?

chevron-up
The 52 week high of iBio, Inc. stock is $3.76, while the 52 week low is $0.79 as of 10 Oct '26.

What is IBIO's market capitalisation today?

chevron-up
IBIO market capitalisation is $9.22M as of October 10, 2026, at 10:12 am IST.

What is IBIO's net income for the last quarter?

chevron-up
IBIO's net income for the last quarter is -10.58B USD.

What is the 5 year returns of IBIO?

chevron-up
The 5 year returns of IBIO is -99.77% as on 10 Oct '26.

What is the high & low stock price of IBIO today?

chevron-up
IBIO stock price hit a high of $0.95 and low of $0.86 as of 10 Oct '26.

Can I buy IBIO shares in India?

chevron-up
Yes. You can buy IBIO in India by opening an international trading account.